Seed Innovations Limited

Seed Innovations Limited

SEED.L
Seed Innovations LimitedGB flagLondon Stock Exchange
2.95
GBp
- -
- -
5.69MMarket Cap
Seed Innovations Limited
SEED.L
(London Stock Exchange)

Recent

price

2.95

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
FRC
- -
0.03
- -
- -
- -
- -
- -
0.03
0.02
-0.02
0.04
-0.02
-0.02
-0.01
- -
- -
Revenue per Share
-0.3
-0.03
-0.05
-0.03
-0.01
-0.03
- -
0.03
0.01
-0.03
0.04
-0.02
-0.02
-0.01
- -
- -
Basic EPS, GAAP
-0.08
-0.06
-0.04
-0.03
- -
- -
- -
- -
- -
- -
- -
- -
- -
-0.02
- -
- -
Free Cash Flow per Basic Share
- -
- -
0.04
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.1
0.1
0.1
-0.33
-0.17
0.12
0.05
0.07
0.1
0.01
0.01
0.01
0.01
0.01
- -
0.01
Book Value per Share
0.36
0.11
0.03
- -
0.03
0.19
0.08
0.1
0.13
0.09
0.14
0.1
0.08
0.07
- -
0.06
Tangible Book Value per Share
5
5
7
7
15
55
133
133
151
162
175
213
213
209
194
190
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
1
4
2
-4
7
-4
-4
-1
- -
- -
Sales/Revenue/Turnover
-49,266.67
-101.4
-29,100
896
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
-1
- -
- -
- -
- -
-1
-1
4
1
-5
7
-5
-4
-2
- -
-1
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-49,533.33
-101.4
-30,200
936
1,558.33
-1,280.87
-95.07
93.88
59.69
125.18
89.78
123.36
117.71
170.42
- -
-312.31
Profit Margin (%)
2
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
2
1
- -
- -
- -
10
10
14
19
14
25
20
16
14
- -
11
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
-297.2
-29
-50.33
- -
- -
- -
-8.9
48.68
11.52
-60.44
348.9
-212.04
-209.64
-102.24
- -
-64.79
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-18.8%
Free Cash Flow
- -
- -
-78.82%
Net Income, GAAP
- -
- -
-71.27%
Sales/Revenue/Turnover
- -
- -
-115.68%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
-1
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
-0.01
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Seed Innovations Limited (SEED.L) is a Guernsey-based closed-ended investment company listed on AIM that provides investors with exposure to disruptive high-growth life sciences and technology ventures, including minority to full ownership stakes in unquoted and quoted small- to medium-sized enterprises with significant intellectual property; its core portfolio comprises investments in biotech firms such as Juvenescence Limited, which develops therapeutics for age-related diseases, Avextra AG, a cannabis-based medicines manufacturer, Clean Food Group Ltd, which produces sustainable oils from food waste, Little Green Pharma, an ASX-listed medicinal cannabis producer, Inveniam Capital Partners, a fintech data platform, and Oxford BioDynamics Plc alongside smaller positions like Portage Biotech Inc.; the company also pursues short-term trading opportunities in liquid assets for liquidity enhancement. Founded in 2006 and headquartered at Obsidian House, La Rue D'Aval, Vale, Guernsey, Seed Innovations focuses geographically on North America, Europe and Asia, with a strategic shift toward robotics, artificial intelligence hardware and software, ancillary services, and established industries impacted by AI productivity gains, while managing its legacy wellness, biotech, pharmaceuticals, fintech and cannabinoid holdings for value realization. Recent developments include a £250,000 investment in Pantheon Resources plc in August 2024, sold three months later for a 35% profit of £87,000, a £125,000 stake in Oxford BioDynamics' February 2025 private placing, portfolio company milestones such as Clean Food Group's partnership with THG Labs, Inveniam's acquisitions of Hedgehog Invest and Factom plus funding from G42, Juvenescence's $76 million Series B-1 round led by M42 in May 2025 with a broader AI therapeutics alliance, Little Green Pharma's acquisition of Health House in February 2025, a £2 million special dividend and ongoing share buybacks reducing ordinary shares outstanding, alongside a board change with Ian Burns stepping down as chairman in June 2025 and Luke Cairns appointed interim chairman.